PEER REVIEW ORIGINAL RESEARCH: EHS & LCA assessment for 7-ACA synthesis A case study for comparing biocatalytic & chemical synthesis
- 1 June 2008
- journal article
- research article
- Published by Mary Ann Liebert Inc in Industrial Biotechnology
- Vol. 4 (2), 180-192
- https://doi.org/10.1089/ind.2008.4.180
Abstract
A Green Technology Comparison framework incorporating a life cycle approach and sustainability metrics has been used to compare the performance, and the environment, health, safety, and life cycle impacts of two synthetic methods used to produce 7-aminocephalosporic acid (7-ACA). The routes under study were a chemical synthetic process and a two-enzyme catalyzed process, both starting from the potassium salt of cephalosporin C. Cradle-to-gate life cycle impact estimations were performed using the Fast Life Cycle Assessment of Synthetic Chemistry (FLASC™) tool and following modular gate-to-gate methodology. The results compare the synthetic efficiency, environment, health, safety, and life cycle metrics for a mature chemical process and a more recent but less developed enzymatic process for making 7-ACA. The chemical process has a higher yield, but a significantly lower reaction mass efficiency and half the mass productivity of the enzymatic process. The chemical process uses more hazardous materials and solvents and requires about 25% more process energy than the enzymatic process. When accounting for the cradle-to-gate environmental life cycle, the chemical process has a larger overall environmental impact, mainly derived from the production of raw materials. In comparison to the enzyme-catalyzed process, the chemical process uses approximately 60% more energy, about 16% more mass (excluding water), has double the greenhouse gas (GHG) impact, and about 30% higher photochemical ozone creation potential (POCP) and acidification impact.Keywords
This publication has 17 references indexed in Scilit:
- Key green chemistry research areas—a perspective from pharmaceutical manufacturersGreen Chemistry, 2007
- Industrial biotechnology for the production of bio-based chemicals – a cradle-to-grave perspectiveTrends in Biotechnology, 2007
- Biocatalysis for pharmaceutical intermediates: the future is nowTrends in Biotechnology, 2007
- Green Chemistry, a Pharmaceutical PerspectiveOrganic Process Research & Development, 2006
- Dispelling the Myths--Biocatalysis in Industrial SynthesisScience, 2003
- The production of fine chemicals by biotransformationsCurrent Opinion in Biotechnology, 2002
- Developing GSK's green technology guidance: methodology for case-scenario comparison of technologiesClean Technologies and Environmental Policy, 2002
- How do you select the “greenest” technology? Development of guidance for the pharmaceutical industryClean Products and Processes, 2001
- Commercial scale biocatalysis: myths and realitiesBioorganic & Medicinal Chemistry, 1999
- Biocatalysts for clean industrial products and processesCurrent Opinion in Microbiology, 1999